Literature DB >> 42540

Crystallization and properties of cathepsin B from rat liver.

T Towatari, Y Kawabata, N Katunuma.   

Abstract

Cathepsin B from rat liver was purified to apparent homogeneity by cell-fractionation, freezing and thawing, acetone treatment, gel filtration, DEAE-Sephadex and CM-Sephadex column chromatography, and was crystallized. The purified enzyme formed spindle-shaped crystals and its homogeneity was proved by disc gel electrophoresis in the presence of sodium dodecyl sulfate and by ultracentrifugal analysis. Its s20,w value was 2.8 S and its relative molecular mass was calculated to be 22,500 (+/- 900) by sedimentation equilibrium analysis. Crystalline cathepsin B was shown to consist of four isozymes with isoelectric points between pH 4.9 and 5.3, the main isozyme having an isoelectric point of pH 5.0. The enzyme was irreversibly inactivated by exposure to weak alkali. The pH optimum was 6.0 with alpha-N-benzoyl-DL-arginine-4-nitroanilide as substrate. Amino acid analysis showed that the enzyme contained hexosamine, glucosamine and galactosamine. Cathepsin B inactivated aldolase, glucokinase, apo-ornithine aminotransferase, and apo-cystathionase, but the rates of inactivation of glucokinase, apo-ornithine aminotransferase, and apocystathionase were lower than that of aldolase. Studies by polyacrylamide gel electrophoresis in the presence and absence of sodium dodecyl sulfate showed that cathepsin B degraded apo-ornithine aminotransferase to two polypeptide chains differing in relative molecular mass and electrophoretic mobility.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 42540     DOI: 10.1111/j.1432-1033.1979.tb06290.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  21 in total

1.  Demonstration and characterization of hippocampal cholinergic neurostimulating peptide (HCNP) processing enzyme activity in rat hippocampus.

Authors:  Y Otsuka; K Ojika
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

2.  Isolation and characterization of cathepsin B from bovine brain.

Authors:  J D Bradley; J N Whitaker
Journal:  Neurochem Res       Date:  1986-06       Impact factor: 3.996

3.  Expression of functional recombinant human procathepsin B in mammalian cells.

Authors:  W P Ren; R Fridman; J R Zabrecky; L D Morris; N A Day; B F Sloane
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Andrzej Wincewicz; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

5.  Muscle fiber degradation in distal myopathy with rimmed vacuoles.

Authors:  T Kumamoto; H Ueyama; S Watanabe; E Kominami; M Ando
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged.

Authors:  K Ii; H Ito; E Kominami; A Hirano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues.

Authors:  M R Buck; D G Karustis; N A Day; K V Honn; B F Sloane
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

8.  Cathepsin B from human renal cortex.

Authors:  A D Gounaris; E E Slater
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

9.  Natural structural variation in enzymes as a tool in the study of mechanism exemplified by a comparison of the catalytic-site structure and characteristics of cathepsin B and papain. pH-dependent kinetics of the reactions of cathepsin B from bovine spleen and from rat liver with a thiol-specific two-protonic-state probe (2,2'-dipyridyl disulphide) and with a specific synthetic substrate (N-alpha-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide).

Authors:  F Willenbrock; K Brocklehurst
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

10.  Oxidative Modifications of Rat Liver Cell Components During Fasciola hepatica Infection.

Authors:  Ewa Siemieniuk; Lidia Kolodziejczyk; Elżbieta Skrzydlewska
Journal:  Toxicol Mech Methods       Date:  2008-06-23       Impact factor: 2.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.